Trade ORIC Pharmaceuticals, Inc. - ORIC CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.07 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 7.44 |
| Open | 7.95 |
| 1-Year Change | -24% |
| Day's Range | 7.43 - 7.95 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 7.64 | 0.05 | 0.66% | 7.59 | 8.00 | 7.40 |
| Feb 20, 2025 | 7.44 | -0.48 | -6.06% | 7.92 | 7.92 | 7.31 |
| Feb 19, 2025 | 7.90 | -0.18 | -2.23% | 8.08 | 8.23 | 7.64 |
| Feb 18, 2025 | 7.81 | -0.53 | -6.35% | 8.34 | 8.76 | 7.45 |
| Feb 14, 2025 | 8.33 | -0.11 | -1.30% | 8.44 | 9.16 | 7.87 |
| Feb 13, 2025 | 8.23 | -1.26 | -13.28% | 9.49 | 9.53 | 7.45 |
| Feb 12, 2025 | 9.41 | -0.03 | -0.32% | 9.44 | 9.60 | 8.71 |
| Feb 11, 2025 | 9.81 | -1.87 | -16.01% | 11.68 | 11.68 | 7.84 |
| Feb 10, 2025 | 11.18 | -1.06 | -8.66% | 12.24 | 14.63 | 10.92 |
| Feb 7, 2025 | 12.21 | -0.17 | -1.37% | 12.38 | 12.91 | 11.86 |
| Feb 6, 2025 | 12.50 | 0.03 | 0.24% | 12.47 | 13.25 | 12.34 |
| Feb 5, 2025 | 12.33 | 1.73 | 16.32% | 10.60 | 12.60 | 10.60 |
| Feb 4, 2025 | 10.69 | 0.53 | 5.22% | 10.16 | 11.89 | 10.16 |
| Feb 3, 2025 | 10.11 | -0.07 | -0.69% | 10.18 | 10.46 | 9.87 |
| Jan 31, 2025 | 10.40 | -0.34 | -3.17% | 10.74 | 10.74 | 10.19 |
| Jan 30, 2025 | 10.71 | -0.48 | -4.29% | 11.19 | 11.26 | 10.70 |
| Jan 29, 2025 | 11.12 | -0.53 | -4.55% | 11.65 | 11.93 | 10.93 |
| Jan 28, 2025 | 11.66 | 0.83 | 7.66% | 10.83 | 11.70 | 10.38 |
| Jan 27, 2025 | 10.80 | 0.77 | 7.68% | 10.03 | 11.03 | 9.89 |
| Jan 24, 2025 | 10.29 | 0.15 | 1.48% | 10.14 | 10.65 | 9.98 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
ORIC Pharmaceuticals, Inc. Company profile
About ORIC Pharmaceuticals Inc
ORIC Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on improving patients’ lives by overcoming resistance in cancer. The Company is focused on developing a diverse pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its experience within three specific areas: hormone-dependent cancers, precision oncology and key tumor dependencies. Its product candidates include ORIC-101, ORIC-533, ORIC-944 and ORIC-114. The Company’s ORIC-101 is a potent and selective small-molecule antagonist of the glucocorticoid receptor (GR), which has been linked to resistance to multiple classes of cancer therapeutics across a variety of solid tumors. The Company’s second product candidate, ORIC-533, is an orally bioavailable, small-molecule inhibitor of CD73, a key node in the adenosine pathway in resistance to chemotherapy-and immunotherapy-based treatment regimens. Its ORIC-944, is being developed for prostate cancer and breast cancer.
Financial summary
BRIEF: For the nine months ended 30 September 2021, ORIC Pharmaceuticals Inc revenues was not reported. Net loss increased 23% to $55.9M. Higher net loss reflects Research and development - Balancing val increase from $15.4M to $36.5M (expense), General and administrative - Balancing increase of 93% to $10.2M (expense), Stock-based Compensation in SGA increase from $1.9M to $5.8M (expense).
| Industry: | Bio Therapeutic Drugs |
240 E. Grand Ave
2nd Floor
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com